Life Sciences
Software

Collaborative Tools For Bold Biologists

At Fearless League, we share your passion for scientific exploration.
We believe the journey of discovery thrives on collaboration and continuous improvement.
This is why we offer:

Unlimited number of teams
Powerful collaboration tools

Streamline teamwork and communication with intuitive features designed to keep your research on track.

plasmid file
Innovative solutions

Stay ahead of the curve with cutting-edge software that empowers you to tackle complex scientific challenges.

Crispr icon
Expert resources

Access a wealth of valuable resources to support your research journey and help you achieve groundbreaking results.

desktop cloud synchronisation
Unwavering support

We're here to partner with you, every step of the way. We believe in open communication and value your feedback to continuously improve our software.

Photo51 Logo

Photo51

Molecular biology software

Empower your team in
less than 3 minutes!

Learn more
Install iconInstall
Import iconImport
Share iconCollaborate
Inventory with preview
CRISPR-Cas tools
 
Split screen
 
Create teams & work together
 
Unlimited installations
 

Unlimited installations,
desktop and cloud!

Try for free
desktop iconcloud icon

Collaborations

Talent-CGT

Talent-CGT is a European initiative to train the next generation of cell and gene therapy specialists. It builds open digital tools and education modules that bring advanced therapy skills into classrooms and labs.

This project receives funding from the European Institute of Innovation and Technology (EIT), a body of the European Union, under the Horizon Europe program.

EIT raw materials logoFunded by EU logoEIT higher education initiative logo
PRIME-AI

PRIME-AI develops next-generation gene therapies by combining prime editing with artificial intelligence. The project creates smarter design tools, a new editing system, and a robust assay to make advanced therapies safer and more precise.

The collaboration project PRIME-AI is co-funded by PPP Subsidy awarded by Health~Holland, Top Sector Life Sciences & Health, to stimulate public-private partnerships.

Health~Holland logo
IPCEI P-SMaRT

IPCEI P-SMaRT accelerates scalable manufacturing platforms for rare disease gene therapies. The project focuses on Duchenne muscular dystrophy and Diamond-Blackfan anemia to make advanced treatments more accessible.

This project has received funding under the Important Projects of Common European Interest (IPCEI) program.

Funded by EU logo